Frontlight ResearchEarly access
Trial site
Loma Linda University Cancer Center
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- Acute lymphoblastic leukaemia2 trials
- Acute myeloid leukaemia2 trials
- Hodgkin lymphoma2 trials
- Aplastic anaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- and 1 more
- Phase
- Phase 12 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Bristol-Myers Squibb2 trials
- Amgen1 trial
- Center for International Blood and Marrow Transplant Research1 trial
- Daiichi Sankyo1 trial
- Incyte Corporation1 trial
- and 2 more
Running trials
Active, not recruiting
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Recruiting
Active, not recruiting
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Active, not recruiting
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Aplastic anaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026